{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-036065","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2024-09-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.234881+00:00","generated_at":"2026-05-31T05:15:19.949604+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Vivos Therapeutics approves new equity plan and amended CEO/CFO employment deals","bullets":["Board approved 2024 Omnibus Plan (subject to stockholder vote) with 1,600,000 shares available for future awards.","Contingent option grants: CEO Huntsman 315,421 ISOs, CFO Amman 149,533 ISOs at $2.62/share, 3-year vesting.","Amended employment agreements effective Jan 1, 2025 raise CEO base salary to $450,000 and CFO to $320,000.","Severance: 12-month salary continuation on non-cause termination; 24 months after change-in-control; full equity vesting.","New plan will replace 2019 Plan; unused shares retired if stockholders approve at 2024 Annual Meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-036065","json":"https://secwatch.observer/filing/0001493152-24-036065.json","markdown":"https://secwatch.observer/filing/0001493152-24-036065.md","text":"https://secwatch.observer/filing/0001493152-24-036065.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224036065/0001493152-24-036065-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315224036065/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:15:19.949604+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}